Position in AMGN
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$231,756
+$6,572 QoQ
Shares Held
640
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#2,751
of 3,140 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Glass Wealth Management Co LLC holds $16,275,469 across 9 Drug Manufacturers - General names. AMGN ranks #8 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,448 | $5,335,065 | |
| 2 | MRK |
Merck & Co., Inc.
|
29,119 | $3,741,791 | |
| 3 | PFE |
Pfizer Inc
|
100,166 | $2,411,997 | |
| 4 | SNY |
Sanofi
|
43,650 | $1,862,109 | |
| 5 | NVS |
Novartis AG
|
11,690 | $1,832,056 | |
| 6 | ABBV |
AbbVie Inc.
|
1,618 | $407,153 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,845 | $233,097 | |
| 8 | AMGN |
Amgen Inc
This page
|
640 | $231,756 |
All Filings in AMGN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $231,756 | 640 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $225,184 | 640 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $209,478 | 640 | Shares | Sole | 2026-02-04 | |
| 2025-06-30 | $210,803 | 755 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $219,642 | 705 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||